17th International Myeloma Workshop - Boston 2019

Thank you!

To all our local organizers, IMS leadership, faculty, presenters, attendees, and sponsors, thank you for making the 17th International Myeloma Workshop (IMW) a great success!

Over 3200 registered delegates attended the 17th IMW, the largest in the history of the workshop. In addition to 150 invited faculty, over 600 study abstracts were presented at the 17th IMW in oral and poster sessions, including 150 from young investigators.

Congratulations to the 40 young investigators who were honored at the 17th IMW, and to Professor Giampaolo Merlini who received the Jan Gosta Waldenstrom Award for lifetime contributions to myeloma; Dr. Constantine Mitisades who received the Kenneth C. Anderson Young Investigator Award for Basic and Translational Research; and Dr. Francesca Gay who received the Bart Barlogie Young Investigator Award for Therapeutics.

The 18th IMW will be held September 8-11, 2021, in Vienna, Austria under the auspices of professors Heinz Ludwig, Hermann Einsele, Hartmut Goldschmidt and Roman Hajek. More information on the 18th IMW will be forthcoming at https://www.myelomasociety.org/

Steve Treon, Paul Richardson, Ken Anderson, Nikhil Munshi
and all the organizers of the 17th IMW

Empowering Patients by Providing the Best Information

Join us in Boston for the latest updates from the International Myeloma Workshop! Our internationally renowned faculty will speak on:

Guiding Treatment Decisions—Prognostic Factors, Genetics, and More (MRD, Maintenance, and Transplant)
Treatments for Newly Diagnosed Patients (Transplant Eligible and Ineligible)
Treatments for Relapsed Myeloma
Immunotherapeutic Approaches to MM, including CAR T-cell and others

There will be ample opportunity to ask questions during the moderated panel discussions.

Download More Information

Register to Attend

IMW Highlights: Patient Symposium Agenda

Schedule	Presentation	Presenter	Time (minutes)
12:00 PM - 1:00 PM	Registration, Reception and Exhibits		60
1:00 PM - 1:15 PM	Opening Remarks	Host/MMRF	15
1:15 PM - 1:30 PM	Presentation Topic 1: Guiding Treatment Decisions—Prognostic Factors, Genetics, and More (MRD, Maintenance, and Transplant)	Speaker 1	15
1:30 PM - 1:45 PM	Presentation Topic 2: Treatments for Newly Diagnosed Patients (Transplant Eligible and Ineligible)	Speaker 2	15
1:45 PM - 2:00 PM	Moderated discussion/Q & A		15
2:00 PM - 2:15 PM	Presentation Topic 3: Treatments for Previously Treated Myeloma	Speaker 3	15
2:15 PM - 2:30 PM	Presentation Topic 4: Immunotherapeutic Approaches to MM	Speaker 4	15
2:30 PM - 2:55 PM	Moderated discussion/Q & A		25
2:55 PM - 3:00 PM	Closing Remarks	Host/MMRF	5
3:00 PM - 3:30 PM	Refreshments and Exhibits		30